> Albany Molecular Research has signed a deal for the stock purchase of Budapest-based ComGenex. Report
> Iomai has cut its IPO to 5 million shares at a price of $7 to $9 each. Release
> Rebel investors in SkyePharma are calling for a special general meeting to force Ian Gowrie-Smith's departure from the board. Gowrie-Smith resigned as chairman a week ago. Report
> The FDA has approved a new indication for Ista's Xibrom eye treatment. Release
> Rigel has received a milestone payment from Merck for their work on ubiquitine ligases. Release
> San Diego-based Stressgen has reorganized with more than $9 million in new funding. Release
> Affymax of Palo Alto, CA, has initiated a Phase II trial of Hematide to treat anemia in cancer patients. Release
> Bayer is licensing two tests from Abbott. Release
> IDM Pharma has released results for its Phase I trial of Collidem Dendritic Cell Vaccine. Release
And Finally... Bill Gates is adding $600 million to his war chest for eradicating TB by 2015. Article